Wang Lan, Yang Wen, Zhu Jia-Qian, Huang Yan-Feng, Zhong Mei, Loo Steven King Fan, Ip Siu Po, Xian Yan-Fang, Lin Zhi-Xiu
School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, China.
Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Toxicol Rep. 2024 Jun 13;13:101682. doi: 10.1016/j.toxrep.2024.101682. eCollection 2024 Dec.
A traditional Chinese herbal medicine formula named Huang-Lian-Jie-Du Decoction (HLJDD) has been used to cure various inflammatory diseases with a long history. However, one component of HLJDD has remarkable liver and kidney toxicities. Therefore, it was altered with to form a modified HLJDD (MHLJDD). In this study, we aimed to evaluate the sub-chronic toxicity of the active fraction of MHLJDD (MHLJDD-F) in rats. Adult rats of both sexes were intragastrically administered with vehicle or MHLJDD-F (at the dose of 170, 340, and 680 mg/kg/day) once daily for 90 days. Half of the rats from each group were kept for an additional 30-day period to observe the drug withdrawal effect. The signs of toxicity and mortality of the rats were observed, and the body weight and food consumption were recorded. Blood was collected for hematological and biochemical analyses and major organs were weighed and harvested for histopathological examinations. The results revealed that no systemic toxicity of MHLJDD-F was found during the experiments. Organ coefficients and pathological alterations of major organs were comparable to the control rats. The no-observed adverse effect level (NOAEL) of MHLJDD-F was found up to 680 mg/kg/day. All these results demonstrated that long-term oral administration of MHLJDD-F did not cause significant toxicity, which is worthy to be widely applied as a new herbal medicine in pre-clinical and clinical studies.
一种名为黄连解毒汤(HLJDD)的传统中药配方长期以来一直用于治疗各种炎症性疾病。然而,HLJDD的一种成分具有显著的肝肾毒性。因此,对其进行了改良以形成改良黄连解毒汤(MHLJDD)。在本研究中,我们旨在评估MHLJDD的活性成分(MHLJDD-F)对大鼠的亚慢性毒性。成年雌雄大鼠每天一次经口灌胃给予赋形剂或MHLJDD-F(剂量为170、340和680mg/kg/天),持续90天。每组一半的大鼠再饲养30天以观察撤药效果。观察大鼠的毒性体征和死亡率,并记录体重和食物摄入量。采集血液进行血液学和生化分析,称重并摘取主要器官进行组织病理学检查。结果显示,实验期间未发现MHLJDD-F的全身毒性。主要器官的脏器系数和病理改变与对照大鼠相当。发现MHLJDD-F的未观察到不良反应水平(NOAEL)高达680mg/kg/天。所有这些结果表明,长期口服MHLJDD-F不会引起明显毒性,这值得在临床前和临床研究中作为一种新的草药广泛应用。